Clinical Trial Update: A Multicenter, Randomized, Double-blind, Placebo-controlled Parallel-group Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of XH-S004 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis [Phase 2]

View source ↗

Summary

A Phase 2 multicenter randomized trial assessing the efficacy and safety of XH-S004 tablets in patients with non-cystic fibrosis bronchiectasis; the study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-cystic Fibrosis Bronchiectasis

Drugs mentioned

• XH-S004 (XH-S004)

Snippet

Sponsor: S-INFINITY Pharmaceuticals Co., Ltd | Conditions: Non-Cystic Fibrosis Bronchiectasis | Phase 2 | Status: NOT_YET_RECRUITING